2023 Speakers Grace Lytle Executive Ocular Medical Director ImmunoGen Gregory Adams Chief Scientific Officer Elucida Oncology Inc. Jennifer Brown Director, Toxicology MacroGenics John Lambert Independent Consultant Attager Consulting Jutta Deckert Executive Director - Translational Research & Development Iksuda Therapeutics Magali Guffroy Head of pathology Abbvie Melanie Frigault Vice President Translational Medicine Vincerx Pharma Melissa Schutten Senior Director & Head Of Pathology Seagen Mike Seganish Senior Principal Scientist & Director - Scientific & Discovery Chemistry Merck & Co Nathan Alves Associate Professor Indiana University School of Medicine Patrick Zweidler-McKay Exec Medical Director ImmunoGen RAKESH DIXIT CEO Bionavigen Ronnie Yeager Project Director/Toxicologist, Emerging Therapeutic Platforms Abbvie Sadhna Shankar, MD, MPH Vice President of Early Phase, Clinical Research, Oncology Eisai Sayumi Yamazoe Senior Principal Scientist Bristol Myers Squibb Carole Harbison Senior Scientist Pathology Takeda Kristin Decker Associate Director Pharmacology & Toxicology Heidelberg Pharma GmbH Stuart Barnscher Director, Preclinical Programs, ADC Therapeutic Development Zymeworks Ursula Matulonis Professor - Medicine Dana-Farber Cancer Institute
